X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs AUROBINDO PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD AUROBINDO PHARMA WYETH LTD/
AUROBINDO PHARMA
 
P/E (TTM) x 27.7 14.7 188.0% View Chart
P/BV x 5.3 3.8 141.3% View Chart
Dividend Yield % 1.3 0.4 308.9%  

Financials

 WYETH LTD   AUROBINDO PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
AUROBINDO PHARMA
Mar-17
WYETH LTD/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,044895 116.7%   
Low Rs818622 131.5%   
Sales per share (Unadj.) Rs298.6254.6 117.3%  
Earnings per share (Unadj.) Rs57.239.3 145.7%  
Cash flow per share (Unadj.) Rs58.446.6 125.4%  
Dividends per share (Unadj.) Rs17.002.50 680.0%  
Dividend yield (eoy) %1.80.3 553.9%  
Book value per share (Unadj.) Rs249.5160.0 156.0%  
Shares outstanding (eoy) m22.72585.88 3.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.13.0 104.7%   
Avg P/E ratio x16.319.3 84.2%  
P/CF ratio (eoy) x15.916.3 97.9%  
Price / Book Value ratio x3.74.7 78.7%  
Dividend payout %29.76.4 466.6%   
Avg Mkt Cap Rs m21,157444,390 4.8%   
No. of employees `0000.514.0 3.5%   
Total wages/salary Rs m40017,678 2.3%   
Avg. sales/employee Rs Th13,787.410,667.8 129.2%   
Avg. wages/employee Rs Th813.01,264.3 64.3%   
Avg. net profit/employee Rs Th2,643.31,645.8 160.6%   
INCOME DATA
Net Sales Rs m6,783149,157 4.5%  
Other income Rs m3531,159 30.4%   
Total revenues Rs m7,136150,316 4.7%   
Gross profit Rs m1,61734,343 4.7%  
Depreciation Rs m274,276 0.6%   
Interest Rs m6667 0.8%   
Profit before tax Rs m1,93830,558 6.3%   
Minority Interest Rs m050 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6327,597 8.3%   
Profit after tax Rs m1,30123,012 5.7%  
Gross profit margin %23.823.0 103.6%  
Effective tax rate %32.624.9 131.2%   
Net profit margin %19.215.4 124.3%  
BALANCE SHEET DATA
Current assets Rs m6,98492,062 7.6%   
Current liabilities Rs m2,05666,223 3.1%   
Net working cap to sales %72.617.3 419.4%  
Current ratio x3.41.4 244.4%  
Inventory Days Days99106 93.7%  
Debtors Days Days2468 35.4%  
Net fixed assets Rs m24462,919 0.4%   
Share capital Rs m227586 38.8%   
"Free" reserves Rs m5,44193,133 5.8%   
Net worth Rs m5,66893,719 6.0%   
Long term debt Rs m251,814 1.4%   
Total assets Rs m7,901162,494 4.9%  
Interest coverage x353.346.8 755.0%   
Debt to equity ratio x00 22.8%  
Sales to assets ratio x0.90.9 93.5%   
Return on assets %16.514.6 113.4%  
Return on equity %22.924.6 93.4%  
Return on capital %34.032.7 104.0%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1575,838 0.0%   
Fx outflow Rs m2,67730,224 8.9%   
Net fx Rs m-2,66245,613 -5.8%   
CASH FLOW
From Operations Rs m92332,786 2.8%  
From Investments Rs m317-17,870 -1.8%  
From Financial Activity Rs m-481-19,153 2.5%  
Net Cashflow Rs m759-4,239 -17.9%  

Share Holding

Indian Promoters % 0.0 54.1 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 8.0 142.1%  
FIIs % 7.2 27.7 26.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 10.2 298.0%  
Shareholders   21,978 69,601 31.6%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   J.B.CHEMICALS  SUVEN LIFE  IPCA LABS  CADILA HEALTHCARE  ALEMBIC LTD  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Firm; Healthcare & Metal Stocks Gain(09:30 am)

Asian stocks are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.17% while the Hang Seng is up 0.95%. The Nikkei 225 is trading up by 0.4%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - FDC LTD. COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS